Maharashtra has strengthened its position as India’s leading pharmaceutical export hub, with pharma exports reaching USD 5.94 billion in FY2025-26. The state accounted for approximately 19% of India’s total pharmaceutical exports, highlighting its growing importance to India’s global healthcare supply chain.
The performance reflects Maharashtra’s combination of pharmaceutical manufacturing capacity, research capabilities, skilled talent and multimodal logistics infrastructure. The state has emerged as a critical link between Indian pharmaceutical producers and international healthcare markets.
Key Highlights
- USD 5.94 billion — Maharashtra’s pharmaceutical exports in FY2025-26
- 19% — Share of India’s total pharmaceutical exports attributed to Maharashtra
- Major export markets — United States, Europe, Africa, Latin America and Asia
- Key products — Generic medicines, APIs, vaccines, biosimilars and specialty drugs
- Major logistics gateways — Jawaharlal Nehru Port and Mumbai Port
- Major pharma clusters — Mumbai, Pune, Aurangabad and Nashik
- Growth drivers — Manufacturing investment, PLI incentives, infrastructure and export-oriented production
Why Maharashtra Is Emerging as a Pharma Export Powerhouse
Maharashtra has developed one of India’s most diversified pharmaceutical ecosystems. The state’s manufacturing base is supported by pharmaceutical companies, research institutions, industrial clusters and a large pool of skilled professionals.
Its production capabilities span several high-value pharmaceutical categories, including:
Pharmaceutical Segment
Export Importance
Generic medicines
Large international demand for affordable medicines
Active Pharmaceutical Ingredients (APIs)
Critical input for global drug manufacturing
Vaccines
Important component of global healthcare supply chains
Biosimilars
Growing demand in international markets
Specialty pharmaceuticals
Higher-value and technology-intensive products
This combination allows Maharashtra to serve multiple international markets while supporting India’s broader ambition to become a global pharmaceutical manufacturing centre.
Logistics Infrastructure Gives Maharashtra an Export Advantage
For pharmaceutical exporters, manufacturing capacity alone is not enough. Temperature-sensitive and time-critical products require reliable transportation, port connectivity, air cargo infrastructure and efficient customs processes.
Maharashtra benefits from an extensive multimodal logistics network connecting manufacturing clusters with international gateways.
Pharma Export Logistics Flow
This connectivity can help pharmaceutical manufacturers move products from production centres to international markets more efficiently.
Maharashtra’s Role in India’s Global Pharmaceutical Supply Chain
The state’s pharmaceutical export strength also contributes to India’s integration into global healthcare supply chains.
Policy support + Manufacturing capacity + R&D + Logistics connectivity = Stronger Pharma Export Competitiveness
Government initiatives such as the Production Linked Incentive (PLI) programme, bulk drug parks and measures aimed at improving the business environment have supported investment and manufacturing expansion across India’s pharmaceutical sector.
For Maharashtra, these initiatives complement an already established industrial ecosystem and logistics network.
Major Export Markets
Maharashtra’s pharmaceutical products reach several important international markets.
Region
Strategic Importance
United States
One of the world's largest pharmaceutical markets
Europe
Major market for medicines and healthcare products
Africa
Strong demand for affordable medicines
Latin America
Expanding pharmaceutical trade opportunities
Asia
Growing healthcare and pharmaceutical demand
The continued demand for affordable and quality medicines creates opportunities for Maharashtra-based manufacturers to expand their international presence.
What Could Drive the Next Phase of Growth?
Maintaining export leadership will depend increasingly on more than manufacturing scale.
Key areas likely to influence Maharashtra’s future pharmaceutical competitiveness include:
- Research and development — Greater investment in new medicines, formulations and advanced pharmaceutical technologies.
- Digital manufacturing — Wider adoption of automation, data analytics and intelligent manufacturing systems.
- Regulatory capability — Strong compliance with increasingly complex international pharmaceutical standards.
- Cold-chain infrastructure — More sophisticated temperature-controlled logistics for sensitive products.
- Port and cargo efficiency — Faster movement of pharmaceutical shipments through India's export gateways.
- Global supply-chain integration — Deeper participation in international pharmaceutical value chains.
Logistics Is Becoming a Strategic Advantage
The Maharashtra pharma story demonstrates an important shift in India’s export economy: manufacturing and logistics are increasingly interconnected.
A pharmaceutical product may be manufactured in an industrial cluster, transported through road or rail networks, processed at a port or air-cargo facility and finally delivered to a healthcare market thousands of kilometres away.
The efficiency of that entire chain can influence export competitiveness.
Conclusion
Maharashtra’s USD 5.94 billion pharmaceutical exports in FY2025-26 underline the state’s importance in India’s global pharmaceutical trade.
Its combination of manufacturing clusters, research capabilities, skilled workforce and multimodal logistics infrastructure provides a strong foundation for continued export growth.
As global demand for medicines and healthcare products increases, Maharashtra is well positioned to remain a key pharmaceutical export gateway for India.
Frequently Asked Questions
How much pharmaceutical did Maharashtra export in FY2025-26?
Maharashtra recorded pharmaceutical exports worth approximately USD 5.94 billion during FY2025-26.
What share of India's pharma exports came from Maharashtra?
Maharashtra accounted for approximately 19% of India’s total pharmaceutical exports during FY2025-26.
Why is Maharashtra important for pharmaceutical exports?
Its importance comes from the combination of pharmaceutical manufacturing, research institutions, skilled talent, industrial clusters and multimodal logistics infrastructure.
Which ports support Maharashtra's pharmaceutical exports?
Major gateways include Jawaharlal Nehru Port (JNPA) and Mumbai Port, supported by road, rail and air-cargo connectivity.
Which pharmaceutical products are exported from Maharashtra?
The state’s pharmaceutical ecosystem includes generic medicines, APIs, vaccines, biosimilars and specialty pharmaceutical products.
